Texas AG accuses Pfizer of ‘intentionally’ overstating Covid-19 vaccine effectiveness; AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion

Taking stock of the drug industry, from the lab to the medicine chest

November 30, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Cindy Ord/Getty Images for Pfizer/BioNTech STAT+ | Texas AG accuses Pfizer of 'intentionally' overstating Covid-19 vaccine effectiveness The lawsuit claims Pfizer conducted a "scheme of serial misrepresentations" and attempted to silence its critics. By Ed Silverman STAT+ | AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company's recent trading price. By Damian Garde With latest tranche, U.K. Biobank has genome sequences from 500,000 people available for research The Biobank has been building its collection over 20 years, with 500,000 volunteers recruited to provide survey responses about their health. By Andrew Joseph

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser